Global Benign Prostatic Hyperplasia Devices Market Outlook 2022
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
Industry Insights
A report titled, “Global Benign Prostatic Hyperplasia Devices Market Outlook 2022” has been recently published by Reports Intellect. The dedicated analysts and researchers have carried out deep-seated research to put forth the present and future scenario of the Benign Prostatic Hyperplasia Devices market. They have provided an in-depth review with accuracy and reliability to give the readers an overall picture.
The global Benign Prostatic Hyperplasia Devices market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Benign Prostatic Hyperplasia Devices market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand, supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type, and application have been elaborated in this report. The consultants at Reports Intellect have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2016-2021) and forecast period (2022-2027).
Segment by Type
- Transurethral Resection of the Prostate (TURP)
- Transurethral Microwave Therapy (TUMT)
- Transurethral Needle Ablation of the Prostate (TUNA)
- Laser Surgery
- Prostatic Stenting
- Others
Segment by Application
- Hospitals and Clinics
- Ambulatory Surgical Centers(ASC)
- Home
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2016-2027. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region. North America, Europe, China and Japan are the major regions studied in the research report.
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at Reports Intellect have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2016-2021. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Lumenis
- Olympus corporation
- Urologix
- Boston Scientific corporation
- Lisa Laser
- Medifocus
- Neotrac
- ProArc Medical LTD
- Urotech GMBH
Frequently Asked Questions
- Which product segment grabbed the largest share in the Benign Prostatic Hyperplasia Devices market?
- How is the competitive scenario of the Benign Prostatic Hyperplasia Devices market?
- Which are the key factors aiding the Benign Prostatic Hyperplasia Devices market growth?
- Which are the prominent players in the Benign Prostatic Hyperplasia Devices market?
- Which region holds the maximum share in the Benign Prostatic Hyperplasia Devices market?
- What will be the CAGR of the Benign Prostatic Hyperplasia Devices market during the forecast period?
- Which application segment emerged as the leading segment in the Benign Prostatic Hyperplasia Devices market?
- What key trends are likely to emerge in the Benign Prostatic Hyperplasia Devices market in the coming years?
- What will be the Benign Prostatic Hyperplasia Devices market size by 2027?
- Which company held the largest share in the Benign Prostatic Hyperplasia Devices market?
1 Benign Prostatic Hyperplasia Devices Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Devices
1.2 Benign Prostatic Hyperplasia Devices Segment by Type
1.2.1 Global Benign Prostatic Hyperplasia Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Transurethral Resection of the Prostate (TURP)
1.2.3 Transurethral Microwave Therapy (TUMT)
1.2.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.2.5 Laser Surgery
1.2.6 Prostatic Stenting
1.2.7 Others
1.3 Benign Prostatic Hyperplasia Devices Segment by Application
1.3.1 Global Benign Prostatic Hyperplasia Devices Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgical Centers(ASC)
1.3.4 Home
1.3.5 Others
1.4 Global Benign Prostatic Hyperplasia Devices Market Size Estimates and Forecasts
1.4.1 Global Benign Prostatic Hyperplasia Devices Revenue 2016-2027
1.4.2 Global Benign Prostatic Hyperplasia Devices Sales 2016-2027
1.4.3 Benign Prostatic Hyperplasia Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 Benign Prostatic Hyperplasia Devices Market Competition by Manufacturers
2.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Benign Prostatic Hyperplasia Devices Manufacturing Sites, Area Served, Product Type
2.5 Benign Prostatic Hyperplasia Devices Market Competitive Situation and Trends
2.5.1 Benign Prostatic Hyperplasia Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Benign Prostatic Hyperplasia Devices Players Market Share by Revenue
2.5.3 Global Benign Prostatic Hyperplasia Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Benign Prostatic Hyperplasia Devices Retrospective Market Scenario by Region
3.1 Global Benign Prostatic Hyperplasia Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Benign Prostatic Hyperplasia Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.3.1 North America Benign Prostatic Hyperplasia Devices Sales by Country
3.3.2 North America Benign Prostatic Hyperplasia Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.4.1 Europe Benign Prostatic Hyperplasia Devices Sales by Country
3.4.2 Europe Benign Prostatic Hyperplasia Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Benign Prostatic Hyperplasia Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Benign Prostatic Hyperplasia Devices Sales by Region
3.5.2 Asia Pacific Benign Prostatic Hyperplasia Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.6.1 Latin America Benign Prostatic Hyperplasia Devices Sales by Country
3.6.2 Latin America Benign Prostatic Hyperplasia Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Country
3.7.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Benign Prostatic Hyperplasia Devices Historic Market Analysis by Type
4.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2016-2021)
4.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2016-2021)
4.3 Global Benign Prostatic Hyperplasia Devices Price by Type (2016-2021)
5 Global Benign Prostatic Hyperplasia Devices Historic Market Analysis by Application
5.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2016-2021)
5.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2016-2021)
5.3 Global Benign Prostatic Hyperplasia Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Lumenis
6.1.1 Lumenis Corporation Information
6.1.2 Lumenis Description and Business Overview
6.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Lumenis Benign Prostatic Hyperplasia Devices Product Portfolio
6.1.5 Lumenis Recent Developments/Updates
6.2 Olympus corporation
6.2.1 Olympus corporation Corporation Information
6.2.2 Olympus corporation Description and Business Overview
6.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Product Portfolio
6.2.5 Olympus corporation Recent Developments/Updates
6.3 Urologix
6.3.1 Urologix Corporation Information
6.3.2 Urologix Description and Business Overview
6.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Urologix Benign Prostatic Hyperplasia Devices Product Portfolio
6.3.5 Urologix Recent Developments/Updates
6.4 Boston Scientific corporation
6.4.1 Boston Scientific corporation Corporation Information
6.4.2 Boston Scientific corporation Description and Business Overview
6.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Portfolio
6.4.5 Boston Scientific corporation Recent Developments/Updates
6.5 Lisa Laser
6.5.1 Lisa Laser Corporation Information
6.5.2 Lisa Laser Description and Business Overview
6.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Product Portfolio
6.5.5 Lisa Laser Recent Developments/Updates
6.6 Medifocus
6.6.1 Medifocus Corporation Information
6.6.2 Medifocus Description and Business Overview
6.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Medifocus Benign Prostatic Hyperplasia Devices Product Portfolio
6.6.5 Medifocus Recent Developments/Updates
6.7 Neotrac
6.6.1 Neotrac Corporation Information
6.6.2 Neotrac Description and Business Overview
6.6.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Neotrac Benign Prostatic Hyperplasia Devices Product Portfolio
6.7.5 Neotrac Recent Developments/Updates
6.8 ProArc Medical LTD
6.8.1 ProArc Medical LTD Corporation Information
6.8.2 ProArc Medical LTD Description and Business Overview
6.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Portfolio
6.8.5 ProArc Medical LTD Recent Developments/Updates
6.9 Urotech GMBH
6.9.1 Urotech GMBH Corporation Information
6.9.2 Urotech GMBH Description and Business Overview
6.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Product Portfolio
6.9.5 Urotech GMBH Recent Developments/Updates
7 Benign Prostatic Hyperplasia Devices Manufacturing Cost Analysis
7.1 Benign Prostatic Hyperplasia Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
7.4 Benign Prostatic Hyperplasia Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Benign Prostatic Hyperplasia Devices Distributors List
8.3 Benign Prostatic Hyperplasia Devices Customers
9 Benign Prostatic Hyperplasia Devices Market Dynamics
9.1 Benign Prostatic Hyperplasia Devices Industry Trends
9.2 Benign Prostatic Hyperplasia Devices Growth Drivers
9.3 Benign Prostatic Hyperplasia Devices Market Challenges
9.4 Benign Prostatic Hyperplasia Devices Market Restraints
10 Global Market Forecast
10.1 Benign Prostatic Hyperplasia Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Benign Prostatic Hyperplasia Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia Devices by Type (2022-2027)
10.2 Benign Prostatic Hyperplasia Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Benign Prostatic Hyperplasia Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia Devices by Application (2022-2027)
10.3 Benign Prostatic Hyperplasia Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Benign Prostatic Hyperplasia Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets